Spark I Acquisition

SPKL

Spark Therapeutics, Inc. is a developer of gene therapy treatments, which treat debilitating genetic diseases. It is a subsidiary of Hoffmann-La Roche.

Insider trades and stock quote 2023-2025

All insider trades at Spark I Acquisition

Subscribe RSS
DateTypeInsiderPositionØ-PriceVolume
No data available
All information without guarantee! No recommendation/consultation! © U.S. Securities and Exchange Commission (SEC)